FABIO FERNANDES MORATO CASTRO

(Fonte: Lattes)
Índice h a partir de 2011
14
Projetos de Pesquisa
Unidades Organizacionais
FM, Faculdade de Medicina
Departamento de Clínica Médica, Faculdade de Medicina - Docente
LIM/60 - Laboratório de Imunologia Clínica e Alergia, Hospital das Clínicas, Faculdade de Medicina - Líder

Resultados de Busca

Agora exibindo 1 - 10 de 11
  • bookPart
    Abordagem clínica do paciente com doenças imunoalérgicas
    (2022) GALVãO, Clóvis Eduardo Santos; CASTRO, Fábio Fernandes Morato
  • bookPart
    Diagnósticos diferenciais em alergia alimentar
    (2022) CASTRO, Fábio Fernandes Morato; CORDóVA, Pablo Michael Torres
  • bookPart
    Medicina de precisão em alergia
    (2022) SANTOS, Keity Souza; LIMA, Karine de Amicis; CASTRO, Fábio Fernandes Morato; KALIL, Jorge
  • bookPart
    Rinite alérgica e rinossinussites
    (2022) CASTRO, Fábio Fernandes Morato; CORDóVA, Pablo Michael Torres
  • article 15 Citação(ões) na Scopus
    Recessive NLRC4-Autoinflammatory Disease Reveals an Ulcerative Colitis Locus
    (2022) STEINER, Annemarie; REYGAERTS, Thomas; PONTILLO, Alessandra; CECCHERINI, Isabella; MOECKING, Jonas; MOGHADDAS, Fiona; DAVIDSON, Sophia; CAROLI, Francesco; GROSSI, Alice; CASTRO, Fabio Fernandes Morato; KALIL, Jorge; GOHR, Florian N.; I, Florian Schmidt; BARTOK, Eva; ZILLINGER, Thomas; HARTMANN, Gunther; GEYER, Matthias; GATTORNO, Marco; MENDONCA, Leonardo Oliveira; MASTERS, Seth L.
    Purpose NLRC4-associated autoinflammatory disease (NLRC4-AID) is an autosomal dominant condition presenting with a range of clinical manifestations which can include macrophage activation syndrome (MAS) and severe enterocolitis. We now report the first homozygous mutation in NLRC4 (c.478G > A, p.A160T) causing autoinflammatory disease with immune dysregulation and find that heterozygous carriers in the general population are at increased risk of developing ulcerative colitis. Methods Circulating immune cells and inflammatory markers were profiled and historical clinical data interrogated. DNA was extracted and sequenced using standard procedures. Inflammasome activation assays for ASC speck formation, pyroptosis, and IL-1 beta/IL-18 secretion confirmed pathogenicity of the mutation in vitro. Genome-wide association of NLRC4 (A160T) with ulcerative colitis was examined using data from the IBD exomes portal. Results A 60-year-old Brazilian female patient was evaluated for recurrent episodes of systemic inflammation from six months of age. Episodes were characterized by recurrent low-grade fever, chills, oral ulceration, uveitis, arthralgia, and abdominal pain, followed by diarrhea with mucus and variable skin rash. High doses of corticosteroids were somewhat effective in controlling disease and anti-IL-1 beta therapy partially controlled symptoms. While on treatment, serum IL-1 beta and IL-18 levels remained elevated. Genetic investigations identified a homozygous mutation in NLRC4 (A160T), inherited in a recessive fashion. Increased ASC speck formation and IL-1 beta/IL-18 secretion confirmed pathogenicity when NLRC4 (A160T) was analyzed in human cell lines. This allele is significantly enriched in patients with ulcerative colitis: OR 2.546 (95% 1.778-3.644), P = 0.01305. Conclusion NLRC4 (A160T) can either cause recessively inherited autoinflammation and immune dysregulation, or function as a heterozygous risk factor for the development of ulcerative colitis.
  • bookPart
    Antileucotrienos
    (2022) ASSIS, João Paulo de; DIAS, Gabriella Melo Fontes Silva; CASTRO, Fábio Fernandes Morato
  • bookPart
    Anti-histamínicos
    (2022) DIAS, Gabriella Melo Fontes Silva; ASSIS, João Paulo de; CASTRO, Fábio Fernandes Morato
  • bookPart
    Apresentação do volume
    (2022) KALIL, Jorge; CASTRO, Fábio Fernandes Morato
  • bookPart
    Alergia a crustáceos
    (2022) POMIECINSKI, Fabiane; CASTRO, Fábio Fernandes Morato
  • bookPart
    Alergia a venenos de himenópteros
    (2022) WATANABE, Alexandra Sayuri; CASTRO, Fábio Fernandes Morato